A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin in cancer patients.
Masashi Kanai
No relevant relationships to disclose
Yoshihiko Otsuka
No relevant relationships to disclose
Kazunori Otsuka
No relevant relationships to disclose
Takafumi Nishimura
No relevant relationships to disclose
Yukiko Mori
No relevant relationships to disclose
Shigemi Matsumoto
No relevant relationships to disclose
Yuzo Kodama
No relevant relationships to disclose
MIchiya Kawaguchi
No relevant relationships to disclose
Etsuro Hatano
No relevant relationships to disclose
Yoshiki Murakami
No relevant relationships to disclose
Atsushi Imaizumi
No relevant relationships to disclose
Tsutomu Chiba
No relevant relationships to disclose
Jun Nishihira
No relevant relationships to disclose
Hiroyuki Shibata
No relevant relationships to disclose